Resource Center
Welcome to our resource center, your comprehensive hub for valuable information and insights in the field of diagnostic testing and precision medicine. As a leading global provider of specialized laboratory testing services, we understand the importance of staying informed and up-to-date in the ever-evolving world of healthcare diagnostics. The resource center is available to empower healthcare professionals, researchers, and industry stakeholders by offering a wide range of educational materials including; whitepapers, case studies, podcasts, videos, e-books and webinars. Whether you are seeking in-depth knowledge about cutting-edge diagnostic technologies, exploring emerging trends in precision medicine, or looking for practical guidance on test interpretation and patient care, our resources center is your go-to destination for reliable and relevant information. Join us on this journey of discovery and innovation as we strive to enhance patient outcomes and advance the field of diagnostic testing together.
Join us for a case-based webinar on the critical role of rapid fungal infection detection in transplant recipients. Dr. Daniel Z. Friedman, MD, will showcase real-world examples demonstrating how rapid PCR testing enhances clinical decision-making and improves patient outcomes. Learn how timely diagnostic insights can support effective treatment when every moment counts. Explore cutting-edge testing solutions that can make a life-saving difference.
View this engaging webinar hosted by Eurofins Viracor, exploring the potential of Torque Teno Virus (TTV) as a biomarker for immune function. TTV plasma load has been shown to reflect the host’s immune status, making it a valuable tool for immunologic monitoring. Research indicates that TTV load is linked to both rejection and infection in solid organ transplant recipients, offering critical insights for patient management...
Download our TTV Risk Stratification Guide to learn more about how TTV monitoring can enhance transplant patient management and improve clinical outcomes.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.